In the BioHarmony Drug Report Database
Ethacrynic acid
Edecrin (ethacrynic acid) is a small molecule pharmaceutical. Ethacrynic acid was first approved as Edecrin on 1982-01-01. It is used to treat ascites, chronic kidney failure, edema, heart failure, and hypertension amongst others in the USA.
Trade Name
|
Edecrin |
|---|---|
Common Name
|
ethacrynic acid |
ChEMBL ID
|
CHEMBL456 |
Indication
|
ascites, chronic kidney failure, edema, heart failure, hypertension, liver cirrhosis, nephrotic syndrome, pulmonary edema |
Drug Class
|
Image (chem structure or protein)